Sequoia Vaccines
Chemicals & Related Products · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1912 Innerbelt Business Center Dr, Saint...Phone Number
(314) 373-5181Website
www.sequoiavaccines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Sequoia Vaccines
Sequoia Vaccines, Inc. is a clinical-stage pharmaceutical company dedicated to the discovery and development of innovative vaccines aimed at preventing bacterial infections, particularly recurrent urinary tract infections (UTIs), and treating specific cancers and lung infections associated with cystic fibrosis. Their product pipeline includes SEQ-400, a FimH vaccine for recurrent UTIs, and drug candidates targeting ovarian/uterine cancer and lung infections in cystic fibrosis patients. The company is committed to combating antimicrobial resistance and cancer through its advanced research programs. With a leadership team boasting over 100 years of combined experience in pharmaceutical R&D and clinical development, Sequoia Vaccines prioritizes patient outcomes in its mission.Explore more
Sequoia Vaccines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sequoia Vaccines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Sequoia Vaccines is spiking on competitors!
Check if Sequoia Vaccines has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Sequoia Vaccines launches new products
Funding: Get notified immidiatlly once Sequoia Vaccines has new funding data
Sequoia Vaccines, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sequoia Vaccines
Click to see if Sequoia Vaccines had a recent Job posting/layoffs
Earning: See what the market has to say on Sequoia Vaccines recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Sequoia Vaccines as Masked Content
Find more new buyers
Compare Similar Companies to Sequoia Vaccines
Compare insights from companies similar to Sequoia Vaccines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sequoia Vaccines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sequoia Vaccines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sequoia Vaccines.
Sequoia Vaccines Tech Stack
A closer look at the technologies used by Sequoia Vaccines
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Left Company
Executive Move
Lateral Move
Executive Move
Julie Hakim has been appointed as Chief Financial Officer & Executive Vice President.
Lateral Move
Executive Move
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sequoia Vaccines
Sign Up For FreeTo access detailed company insights
Sequoia Vaccines, Inc. is a clinical-stage pharmaceutical company dedicated to the discovery and development of innovative vaccines aimed at preventing bacterial infections, particularly recurrent urinary tract infections (UTIs), and treating specific cancers and lung infections associated with cystic fibrosis. Their product pipeline includes SEQ-4... Read More
